- Home
- IOTR vs BOLD Comparison
IOTR vs BOLD Comparison
Compare IOTR & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- BOLD
- Stock Information
- Founded
- IOTR 2019
- BOLD 2018
- Country
- IOTR Singapore
- BOLD United States
- Employees
- IOTR N/A
- BOLD N/A
- Industry
- IOTR
- BOLD
- Sector
- IOTR
- BOLD
- Exchange
- IOTR NYSE
- BOLD Nasdaq
- Market Cap
- IOTR 11.5M
- BOLD 24.4M
- IPO Year
- IOTR 2025
- BOLD 2024
- Fundamental
- Price
- IOTR $0.47
- BOLD $1.19
- Analyst Decision
- IOTR
- BOLD Buy
- Analyst Count
- IOTR 0
- BOLD 3
- Target Price
- IOTR N/A
- BOLD $4.00
- AVG Volume (30 Days)
- IOTR 693.0K
- BOLD 105.1K
- Earning Date
- IOTR 01-01-0001
- BOLD 08-11-2025
- Dividend Yield
- IOTR N/A
- BOLD N/A
- EPS Growth
- IOTR N/A
- BOLD N/A
- EPS
- IOTR N/A
- BOLD N/A
- Revenue
- IOTR $10,478,550.00
- BOLD N/A
- Revenue This Year
- IOTR N/A
- BOLD N/A
- Revenue Next Year
- IOTR N/A
- BOLD N/A
- P/E Ratio
- IOTR N/A
- BOLD N/A
- Revenue Growth
- IOTR 22.27
- BOLD N/A
- 52 Week Low
- IOTR $0.31
- BOLD $1.00
- 52 Week High
- IOTR $5.98
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- BOLD N/A
- Support Level
- IOTR N/A
- BOLD N/A
- Resistance Level
- IOTR N/A
- BOLD N/A
- Average True Range (ATR)
- IOTR 0.00
- BOLD 0.00
- MACD
- IOTR 0.00
- BOLD 0.00
- Stochastic Oscillator
- IOTR 0.00
- BOLD 0.00
About IOTR IOTHREE LIMITED
iOThree Ltd is a provider of maritime digital technologies, including satellite connectivity and digitalization solutions in Singapore, focused on facilitating the maritime industry towards digital transformation. It offers shipboard infrastructure to customers by designing and installing the necessary satellite connectivity solution, IT equipment, shipboard equipment (such as equipment relating to navigation systems, automatic identification system, etc.), and JARVISS, a digitalization platform on the vessels of customers. The group's operating segments are: Satellite connectivity solution, which generates key revenue, and Digitalization and other solution. Geographically, it generates maximum revenue from Singapore, and rest from Israel, Malaysia, Vietnam, Thailand, and other regions.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.